-
Resazurin Cell Viability Assay Kit: Redox to Biology
2026-09-03
The Resazurin Cell Viability Assay Kit provides a sensitive, non-toxic cell viability assay for connecting treatment responses with cellular redox biology. Using parthenolide research as a model, this guide explains how to distinguish metabolic suppression from apoptosis and design stronger screening workflows.
-
PRMT5, Splicing, and Glutamine Vulnerability in Neuroblastom
2026-09-03
This Cancer Letters study shows that MYCN-amplified neuroblastoma is unusually dependent on PRMT5-controlled RNA splicing, epitranscriptomic regulation, and glutamine metabolism. Its integrated transcriptomic, isotope-tracing, molecular-validation, and mouse-model analyses connect spliceosomal disruption to loss of GLS protein and provide a mechanistic framework for cancer metabolism research.
-
MRSA Extracellular Vesicles Drive OSCC via IL-8
2026-09-02
This 2026 study identifies extracellular vesicles from methicillin-resistant Staphylococcus aureus (MRSA) as active drivers of oral squamous cell carcinoma (OSCC) cell proliferation and tumor growth. By combining MRSA–MSSA vesicle comparisons with cellular signaling experiments and in vivo IL-8/CXCR1 perturbation, the work connects antibiotic resistance biology with tumor-promoting host responses.
-
Alternariol: From Food Toxin to Fibrosis Signal
2026-09-02
A translational framework for using Alternariol and AOH to connect cytochrome P450 metabolism, hepatic stellate cell activation, apoptosis, and emerging liver-fibrosis mechanisms.
-
Cyclodextrin Nano-Adsorbents for Uremic Toxins
2026-09-01
The reference study combines magnetic iron-oxide nanoparticles with α-, β-, or γ-cyclodextrin coatings to investigate how surface chemistry and incubation time govern uremic-toxin adsorption. Its central finding—that adsorption was not simply determined by metabolite concentration—supports more nuanced designs for selectively removing protein-bound toxins and for evaluating candidate analytes such as 4-ethylphenyl sulfate.
-
Hydroxyl-Radical Degradation of Dimetridazole
2026-09-01
This study uses quantum-chemical calculations to resolve how hydroxyl radicals degrade Dimetridazole and ornidazole in water, combining reaction pathways, kinetics, and toxicity prediction. Its main practical contribution is showing that rapid disappearance of the parent compound does not necessarily eliminate environmental risk because early transformation products may be more toxic than the starting drug.
-
AZD1480: A Practical JAK2 Inhibitor Workflow
2026-08-31
AZD1480 connects JAK2 phosphorylation, STAT3-dependent survival, and tumor-cell behavior in mechanism-first cancer assays. Its strongest use cases span myeloma models, cytokine-driven immune–tumor systems, and combination studies where pathway-specific rescue experiments are essential.
-
Cisapride (R 51619) in Cardiac Safety Assays
2026-08-31
Cisapride (R 51619) provides a practical dual-mechanism tool for connecting 5-HT4 receptor biology with hERG-linked cardiac safety phenotypes. This guide shows how to deploy it in iPSC-cardiomyocyte imaging, electrophysiology, concentration-response studies, and deep-learning-enabled cardiotoxicity workflows.
-
MMP-Responsive Hydrogel for Fibrous Dysplasia
2026-08-30
This reference study develops an injectable hyaluronic acid hydrogel containing triglycerol monostearate nanoparticles for matrix metalloproteinase-responsive delivery of the RANKL inhibitor AS2676293. In a GNASR201C fibrous dysplasia mouse model, perilesional treatment reduced lesion progression and improved bone microarchitecture, supporting lesion-directed drug delivery as a preclinical alternative to sustained systemic inhibition.
-
Partial BACE Inhibition and Synaptic Transmission
2026-08-29
Satir et al. examined whether moderate β-secretase inhibition can lower amyloid beta secretion without disrupting neuronal communication. Using primary rat cortical cultures and optical electrophysiology, the study identified a functional window in which partial inhibition reduced amyloid production while preserving synaptic transmission, offering a useful framework for Alzheimer’s disease treatment research.
-
NBC19: NLRP3 Inflammasome Inhibitor Workflows
2026-08-28
NBC19 enables concentration-guided studies of NLRP3-driven IL-1β signaling in differentiated THP1 cells, with practical workflows for Nigericin and ATP challenge models. Its value extends to exploratory cancer-inflammation assays when cytokine measurements are paired with careful phenotyping rather than interpreted as proof of causality.
-
From mRNA Uptake to Translation: A Translational Playbook
2026-08-28
A thought-leadership guide to using ARCA Cy5 EGFP mRNA (5-moUTP) as a mechanistic control for separating delivery, localization, innate immune effects, and translation in mammalian-cell and oncology-focused mRNA programs.
-
Bivalent mRNA Vaccine Broadens SARS-CoV-2 Protection
2026-08-27
This 2024 preclinical study evaluates RQ3025, a broad-spectrum bivalent mRNA vaccine designed around conserved and variant-associated SARS-CoV-2 spike mutations. Across several animal models, RQ3025 induced cross-variant neutralizing antibodies, protected vaccinated rats against emerging variants, promoted a Th1-biased response, and showed no evident organ pathology at a high dose.
-
EdU Readouts for Implantable Tumor Treating Fields
2026-08-27
Implantable Tumor Treating Fields could make localized glioblastoma therapy more precise, but translational progress depends on measuring how tumor cells respond across the cell cycle. This article explains how EdU Imaging Kits (488) can complement device engineering with direct S-phase DNA synthesis measurement, while clarifying assay design, competitive advantages, and the limits of current evidence.
-
IGF2BP1–TUBB4B Signaling in Liver Fibrosis
2026-08-26
The reference study identifies an m6A-dependent IGF2BP1/TUBB4B/FAK pathway that promotes hepatic stellate cell activation, proliferation, and migration. Its combination of transcriptomic data integration with genetic and pharmacological perturbation provides a mechanistic framework for studying RNA stability in liver fibrogenesis.